NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - Vaxart, Inc. - 5.02 / 7.01 / 9.01

Filed: 2026-04-23 AccNo: 0001437749-26-013195 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/23 20:45 UTC
首次发现04/23 20:48 UTC
热度107.3
重要度84
情绪-0.02

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 940 字符

Form 8-K - Current report: SEC Accession No. 0001437749-26-013195

Filing Date: 2026-04-23

Accepted: 2026-04-23 16:45:14

Documents: 13

Period of Report: 2026-04-23

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Vaxart, Inc. (Filer) CIK : 0000072444 (see all company filings) EIN. : 591212264 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 26889329 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | FORM 8-K | vxrt20260423_8k.htm iXBRL | 8-K

2 | EXHIBIT 99.1 | ex_949823.htm | EX-99.1

3 | XBRL TAXONOMY EXTENSION SCHEMA | vxrt-20260423.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | vxrt-20260423_def.xml | EX-101.DEF